The spinal muscular atrophy protein SMN affects Drosophila germline nuclear organization through the U body-P body pathway.

The spinal muscular atrophy protein SMN affects Drosophila germline nuclear organization through the U body-P body pathway.

Survival motor neuron protein (SMN) is the determining factor for the human neurodegenerative disease spinal muscular atrophy (SMA). SMN is critical for small nuclear ribonucleoprotein (snRNP) assembly. Using Drosophila oogenesis as a model system, we show that mutations in smn cause abnormal nuclea...

書誌詳細
主要な著者:	Lee, L, Davies, SE, Liu, J
フォーマット:	Journal article
言語:	English
出版事項:	2009

類似資料

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
著者:: Bowerman, M, 等
出版事項: (2017)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
著者:: Bowerman, M, 等
出版事項: (2017)

SMN post-translational modifications in spinal muscular atrophy
著者:: Giulietta M. Riboldi, 等
出版事項: (2023-02-01)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
著者:: Melissa Bowerman, 等
出版事項: (2017-08-01)

Spinal muscular atrophy in Venezuela: quantitative analysis of SMN1 and SMN2 genes
著者:: Yuri Yépez, 等
出版事項: (2020-06-01)

Molecular Crosstalk Between Non-SMN-Related and SMN-Related Spinal Muscular Atrophy
著者:: Darija Šoltić, 等
出版事項: (2020-03-01)

Therapy Development for Spinal Muscular Atrophy in SMN Independent Targets
著者:: Li-Kai Tsai
出版事項: (2012-01-01)

CORRIGENDUM to Molecular Crosstalk Between Non-SMN-Related and SMN-Related Spinal Muscular Atrophy
出版事項: (2020-04-01)

The Need for SMN-Independent Treatments of Spinal Muscular Atrophy (SMA) to Complement SMN-Enhancing Drugs
著者:: Niko Hensel, 等
出版事項: (2020-02-01)

SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy
著者:: Valeria Valsecchi, 等
出版事項: (2023-11-01)

The spinal muscular atrophy disease protein SMN is linked to the Golgi network.
著者:: Chen-Hung Ting, 等
出版事項: (2012-01-01)

Quantitative and structural features of the SMN1 and SMN2 genes in patients with spinal muscular atrophy 5q
著者:: A. I. Vlasenko, 等
出版事項: (2024-12-01)

Restoring SMN Expression: An Overview of the Therapeutic Developments for the Treatment of Spinal Muscular Atrophy
著者:: Tejal Aslesh, 等
出版事項: (2022-01-01)

Molecular and Epidemiological Characterization of SMN Genes in Cuban Patients with Spinal Muscular Atrophy
著者:: Fabián Lombillo-Alfonso, 等
出版事項: (2020-01-01)

Molecular And Epidemiological Characterization Of SMN Genes In Cuban Patients With Spinal Muscular Atrophy
著者:: Fabián Lombillo, 等
出版事項: (2019-05-01)

Targeting SR proteins improves SMN expression in spinal muscular atrophy cells.
著者:: Claribel D Wee, 等
出版事項: (2014-01-01)

What could be the function of the spinal muscular atrophy-causing protein SMN in macrophages?
著者:: Ines Tapken, 等
出版事項: (2024-05-01)

Motor defects in a Drosophila model for spinal muscular atrophy result from SMN depletion during early neurogenesis.
著者:: Stuart J Grice, 等
出版事項: (2022-07-01)

Analysis of the survival of motor neuron (SMN1) gene mutations in Spinal Muscular Atrophy through models
著者:: Owen, N, 等
出版事項: (2002)

Temperature-sensitive spinal muscular atrophy-causing point mutations lead to SMN instability, locomotor defects and premature lethality in Drosophila
著者:: Amanda C. Raimer, 等
出版事項: (2020-05-01)

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy
著者:: Niba, Emma Tabe Eko, 等
出版事項: (2022)

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy
著者:: Niba, Emma Tabe Eko, 等
出版事項: (2022)

P719: SMN1 deletion and silent carrier screening for spinal muscular atrophy
著者:: Poh San Lai, 等
出版事項: (2024-01-01)

Abnormal motor phenotype in the SMNΔ7 mouse model of spinal muscular atrophy
著者:: Matthew E.R. Butchbach, 等
出版事項: (2007-08-01)

The neuromuscular impact of symptomatic SMN restoration in a mouse model of spinal muscular atrophy
著者:: W. Arnold, 等
出版事項: (2016-03-01)

Investigation of a recombinant SMN protein delivery system to treat spinal muscular atrophy
著者:: Anderton Ryan, 等
出版事項: (2014-03-01)

Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes
著者:: Amparo Garcia-Lopez, 等
出版事項: (2018-05-01)

Modeling spinal muscular atrophy in Drosophila.
著者:: Chang, H, 等
出版事項: (2008)

Modeling spinal muscular atrophy in Drosophila.
著者:: Howard Chia-Hao Chang, 等
出版事項: (2008-09-01)

Depletion of SMN protein in mesenchymal progenitors impairs the development of bone and neuromuscular junction in spinal muscular atrophy
著者:: Sang-Hyeon Hann, 等
出版事項: (2024-02-01)

P423: SMN1 SMN2 gene-specific sequencing enhances the clinical sensitivity of spinal muscular atrophy diagnostic testing
著者:: Matthew Avenarius, 等
出版事項: (2023-01-01)

Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
著者:: Winkelsas, AM
出版事項: (2020)

SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy.
著者:: Wishart, T, 等
出版事項: (2010)

Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
著者:: Winkelsas, AM, 等
出版事項: (2021)

Hepatocyte-intrinsic SMN deficiency drives metabolic dysfunction and liver steatosis in spinal muscular atrophy
著者:: Leow, Damien Meng-Kiat, 等
出版事項: (2024)

Patient-specific responses to SMN2 splice-modifying treatments in spinal muscular atrophy fibroblasts
著者:: Ilaria Signoria, 等
出版事項: (2024-12-01)

Biomarker for Spinal Muscular Atrophy: Expression of SMN in Peripheral Blood of SMA Patients and Healthy Controls.
著者:: Christian Czech, 等
出版事項: (2015-01-01)

Targeting the 5′ untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
著者:: Audrey M. Winkelsas, 等
出版事項: (2021-03-01)

Deletion of smn-1, the Caenorhabditis elegans ortholog of the spinal muscular atrophy gene, results in locomotor dysfunction and reduced lifespan.
著者:: Briese, M, 等
出版事項: (2009)

Characteristics of genetic changes in the <i>SMN1</i> gene in spinal muscular atrophy 5q
著者:: A. V. Dil, 等
出版事項: (2022-09-01)